Intravenous Thrombolysis after Dabigatran Reversal with a Specific Antidote Idarucizumab


Authors: D. Šaňák 1;  P. Dušek 2;  B. Matušková 3;  F. Čtvrtlík 4
Authors‘ workplace: Komplexní cerebrovaskulární centrum, Neurologická klinika LF UP a FN Olomouc 1;  Oddělení urgentního příjmu, FN Olomouc 2;  Neurologické oddělení, Nemocnice Kroměříž, a. s. 3;  Radiologická klinika LF UP a FN Olomouc 4
Published in: Cesk Slov Neurol N 2017; 80/113(Online only): 0
Category: No. 4
doi: 10.14735/amcsnn2017474


Sources

1. Škoda O, Herzig R, Mikulík R, et al. Klinický standard pro diagnostiku a léčbu pacientů s ischemickou cévní mozkovou příhodou a s tranzitorní ischemickou atakou – verze 2016. Cesk Slov Neurol N 2016;79/112(3):351–63.

2. Neumann J, Tomek A, Školoudík D, et al. Doporučený postup pro intravenózní trombolýzu v léčbě akutního mozkového infarktu – verze 2014. Cesk Slov Neurol N 2014;77/110(3):381–5.

3. Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al.; American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2016;47(2):581–641. doi: 10.1161/STR.0000000000000086.

4. Schiele F, van Ryn J, Canada K, et al. A specific antidote for dabigatran: functional and structural characterization. Blood 2013;121(18):3554–62. doi: 10.1182/blood-2012-11-468207.

5. Glund S, Stangier J, Schmohl M, et al. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Lancet 2015;386(9994):680–90. doi: 10.1016/S0140-6736(15)60732-2.

6. Pollack CV jr, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015;373(6):511–520. doi: 10.1056/NEJMoa1502000.

7. Státní ústav pro kontrolu léčiv. SPC přípravku Praxbind®. [cit. 2017 20 Čer]. Dostupné z URL: http://www.sukl.cz/modules/medication/detail.php?code=0209048&tab=texts.

8. Berrouschot J, Stoll A, Hogh T, et al. Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant after Antagonization with Idarucizumab. Stroke 2016;47(7):1936–8. doi: 10.1161/STROKEAHA.116.013550.

9. Schäfer N, Müller A, Wüllner U. Systemic Thrombolysis for Ischemic Stroke after Antagonizing Dabigatran with Idarucizumab – a Case Report. J Stroke Cerebrovasc Dis 2016;25(8):e126–7. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.006.

10. Kafke W, Kraft P. Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a case report. Case Rep Neurol 2016;8(2):140–4. doi: 10.1159/000447531.

11. Gawehn A, Ayari Y, Heuschkel C, et al. Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report. J Med Case Rep 2016;10(1):269.

12. Schulz JG, Kreps B. Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke. J Neurol Sci 2016;370:44. doi: 10.1016/j.jns.2016.09.010.

13. Mutzenbach JS, Pikija S, Otto F, et al. Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab –a case report. Ann Clin Transl Neurol 2016;3(11):889–92. doi: 10.1002/acn3.346.

14. Diener HC, Bernstein R, Butcher K, et al. Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion. Int J Stroke 2017;12(1):9–12. doi: 10.1177/1747493016669849.

15. FDA approved drugs database Praxbind prescribing information. Boehringer Ingelheim International GmbH; 2015. [accessed 2017 20 Jun]. Available from URL:

http://www.Accessdata.Fda.Gov/drugsatfda_docs/label/2015/761025lbl.Pdf.

16. van Ryn J, Schurer J, Fischer D. Abstract wp73: No influence of Dabigatran or its specific reversal agent, Idarucizumab, on rtpa-induced thrombolysis of clots in human plasma: an in vitro study Stroke 2016;47:AWP73.

Labels
Paediatric neurology Neurosurgery Neurology
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

×